The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Cha Albert since year 2005.
The trader's CIK number is 1397906.
At the time of this reporting, Cha Albert is the Director of Menlo Therapeutics, Inc. .
(stock ticker symbol MNLO).
See this page for all insider trading activities at Menlo Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-25||MNLO||Menlo Therapeutics, Inc.||Buy||294,118||17.00||5,000,006|
|2017-05-09||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Buy||470,000||17.00||7,990,000|
|2015-10-13||ACRS||Aclaris Therapeutics, Inc.||Buy||454,545||11.00||4,999,995|
|2015-10-07||ACRS||Aclaris Therapeutics, Inc.||Buy||13,352||11.00||146,872|
|2015-07-21||DNAI||Pronai Therapeutics Inc||Buy||220,000||17.00||3,740,000|
|2015-04-14||CBYL||Carbylan Therapeutics, Inc.||Buy||1,012,500||5.00||5,062,500|
|2008-02-12||BIOD||Albireo Pharma, Inc.||Sale||132,000||15.50||2,046,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cha Albert (Director of Menlo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.